Evidence map›Paper›PMID 38568963›Full record

ArticlePloS one2024

EndoGeneAnalyzer: A tool for selection and validation of reference genes.

Eliel Barbosa Teixeira, André Salim Khayat, Paulo Pimentel Assumpção, Samir Mansour Casseb, Caroline Aquino Moreira-Nunes, Fabiano Cordeiro Moreira

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Biomedicines · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eliel Barbosa TeixeiraOncology Research Center, Federal University of Pará, Belém, Pará, Brazil.ORCID 0000-0001-5102-1811
André Salim KhayatOncology Research Center, Federal University of Pará, Belém, Pará, Brazil.
Paulo Pimentel AssumpçãoOncology Research Center, Federal University of Pará, Belém, Pará, Brazil.
Samir Mansour CassebOncology Research Center, Federal University of Pará, Belém, Pará, Brazil.ORCID 0000-0002-7419-3381
Caroline Aquino Moreira-NunesOncology Research Center, Federal University of Pará, Belém, Pará, Brazil.ORCID 0000-0001-5845-3481
Fabiano Cordeiro MoreiraOncology Research Center, Federal University of Pará, Belém, Pará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The selection of proper reference genes is critical for accurate gene expression analysis in all fields of biological and medical research, mainly because there are many distinctions between different tissues and specimens. Given this variability, even in known classic reference genes, demands of a comprehensive analysis platform is needed to identify the most suitable genes for each study. For this purpose, we present an analysis tool for assisting in decision-making in the analysis of reverse transcription-quantitative polymerase chain reaction (RT-qPCR) data. EndoGeneAnalyzer, an open-source web tool for reference gene analysis in RT-qPCR studies, was used to compare the groups/conditions under investigation. This interactive application offers an easy-to-use interface that allows efficient exploration of datasets. Through statistical and stability analyses, EndoGeneAnalyzer assists in the select of the most appropriate reference gene or set of genes for each condition. It also allows researchers to identify and remove unwanted outliers. Moreover, EndoGeneAnalyzer provides a graphical interface to compare the evaluated groups, providing a visually informative differential analysis.

Indexed as

Gene Expression ProfilingReal-Time Polymerase Chain ReactionReference StandardsReverse Transcriptase Polymerase Chain Reaction

Identifiers

PMID38568963
PMCPMC10990236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.